BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,182,838

« Back to Dashboard

Which drugs does patent 8,182,838 protect, and when does it expire?

Patent 8,182,838 protects SEEBRI and UTIBRON and is included in two NDAs.

This patent has fifty-seven patent family members in twenty-two countries.

Summary for Patent: 8,182,838

Title:Dry powder composition comprising co-jet milled particles for pulmonary inhalation
Abstract: The present invention relates to particles and to methods of making particles. In particular, the invention relates to methods of making composite active particles comprising a pharmaceutically active material for pulmonary inhalation, the method comprising a jet milling process.
Inventor(s): Morton; David (Chippenham, GB), Staniforth; John (Chippenham, GB)
Assignee: Vectura Limited (Chippenham, GB)
Application Number:10/571,146
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sunovion Pharms Inc
POWDER;INHALATION207923-001Oct 29, 2015RXYesYes► Subscribe► SubscribeY
Sunovion Pharms Inc
glycopyrrolate ; indacaterol maleate
POWDER;INHALATION207930-001Oct 29, 2015RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,182,838

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0321607.4Sep 15, 2003
PCT Information
PCT FiledSeptember 15, 2004PCT Application Number:PCT/GB2004/003996
PCT Publication Date:March 24, 2005PCT Publication Number: WO2005/025536

International Patent Family for Patent: 8,182,838

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Denmark1663155► Subscribe
European Patent Office1613323► Subscribe
European Patent Office1617820► Subscribe
European Patent Office1663155► Subscribe
European Patent Office1663164► Subscribe
European Patent Office1663180► Subscribe
European Patent Office1670438► Subscribe
European Patent Office2286797► Subscribe
Spain2377205► Subscribe
United Kingdom0321607► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
Boehringer Ingelheim
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus